Dr. David Laubli, DO

NPI: 1851955389
Total Payments
$569.91
2022 Payments
$120.55
Companies
7
Transactions
14
Medicare Patients
73
Medicare Billing
$6,058

Payment Breakdown by Category

Food & Beverage$569.91 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $569.91 14 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $198.40 6 $0 (2021)
Allergan Inc. $108.87 1 $0 (2019)
ABIOMED $103.49 1 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $97.84 2 $0 (2022)
Merck Sharp & Dohme Corporation $35.37 2 $0 (2021)
AstraZeneca Pharmaceuticals LP $14.62 1 $0 (2021)
JAZZ PHARMACEUTICALS INC. $11.32 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2022 $120.55 2 ABIOMED ($103.49)
2021 $150.77 6 Boehringer Ingelheim Pharmaceuticals, Inc. ($80.78)
2020 $189.72 5 Janssen Pharmaceuticals, Inc ($170.14)
2019 $108.87 1 Allergan Inc. ($108.87)

All Payment Transactions

14 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/27/2022 ABIOMED Impella (Device) Food and Beverage In-kind items and services $103.49 General
Category: Cardiology/Vascular Diseases
04/06/2022 Boehringer Ingelheim Pharmaceuticals, Inc. GILOTRIF (Drug) Food and Beverage In-kind items and services $17.06 General
Category: ONCOLOGY
11/05/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.92 General
Category: Cardiovascular & Metabolism
09/23/2021 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $80.78 General
08/27/2021 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $14.62 General
Category: Cardiovascular and Metabolism
04/06/2021 Merck Sharp & Dohme Corporation DIFICID (Drug), RECARBRIO, ZINPLAVA Food and Beverage In-kind items and services $15.79 General
Category: INFECTIOUS DISEASE
03/24/2021 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug), VYXEOS Food and Beverage In-kind items and services $11.32 General
Category: HEMATOLOGY/ONCOLOGY
03/10/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.34 General
Category: Cardiovascular & Metabolism
10/16/2020 Merck Sharp & Dohme Corporation ZERBAXA (Drug), RECARBRIO Food and Beverage In-kind items and services $19.58 General
Category: INFECTIOUS DISEASE
09/22/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $11.88 General
Category: Cardiovascular & Metabolism
06/22/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.08 General
Category: Cardiovascular & Metabolism
02/20/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $124.88 General
Category: Cardiovascular & Metabolism
01/26/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.30 General
Category: Cardiovascular & Metabolism
09/18/2019 Allergan Inc. TEFLARO (Drug) Food and Beverage In-kind items and services $108.87 General
Category: ANTI-INFECTIVE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 73 102 $16,690 $6,058
Total Patients
73
Total Services
102
Medicare Billing
$6,058
Procedure Codes
2

All Medicare Procedures & Services

2 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 24 50 $9,150 $3,045 33.3%
99497 Advance care planning, first 30 minutes Facility 2023 49 52 $7,540 $3,013 40.0%

About Dr. David Laubli, DO

Dr. David Laubli, DO is a Hospice and Palliative Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2019. The National Provider Identifier (NPI) number assigned to this provider is 1851955389.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Laubli, DO has received a total of $569.91 in payments from pharmaceutical and medical device companies, with $120.55 received in 2022. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($569.91).

As a Medicare-enrolled provider, Laubli has provided services to 73 Medicare beneficiaries, totaling 102 services with total Medicare billing of $6,058. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.

Practice Information

  • Specialty Hospice and Palliative Medicine
  • Location Columbus, OH
  • Active Since 04/30/2019
  • Last Updated 10/03/2023
  • Taxonomy Code 207RH0002X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1851955389

Products in Payments

  • XARELTO (Drug) $198.40
  • TEFLARO (Drug) $108.87
  • Impella (Device) $103.49
  • ZERBAXA (Drug) $19.58
  • GILOTRIF (Drug) $17.06
  • DIFICID (Drug) $15.79
  • BRILINTA (Drug) $14.62
  • ZEPZELCA (Drug) $11.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hospice and Palliative Medicine Doctors in Columbus